Search Within

Xin Pei

Formats
  1. Journal Article (71)
  2. Meeting Abstract (65)
Groups
  1. Sloan Kettering Institute Postdocs (136)
  2. Radiation Oncology, Department of (125)
  3. Survivorship Research (96)
  4. Gynecology Disease Management Team (88)
  5. GDMT, Radiation Oncology (69)
  6. GSK Faculty (51)

More Groups

People
  1. Michael Zelefsky (79)
  2. Marisa Kollmeier (65)
  3. Nadeem Riaz (41)
  4. Yoshiya Yamada (38)
  5. Zhigang Zhang (32)
  6. Brett Cox (29)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (59)
  2. Brachytherapy (8)
  3. Journal of Clinical Oncology (6)
  4. Annals of Oncology (5)
  5. BJU International (5)
  6. European Urology (5)

More Publications

Publishers
  1. Elsevier Inc. (65)
  2. Elsevier Science, Inc. (20)
  3. Oxford University Press (9)
  4. American Society of Clinical Oncology (8)
  5. Nature Publishing Group (7)
  6. Wiley Blackwell (6)

More Publishers

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The natural history and patterns of failure after recurrence in patients with locally advanced head and neck squamous cell carcinoma treated with modern chemoradiation techniques
    Meeting Abstract

    Leeman, J.; Li, J. G.; Pei, X.; Venigalla, P.; Zumsteg, Z.; Katsoulakis, E.; Lupovitch, E.; McBride, S.; Tsai, J.; Boyle, J.; more...
    Journal of Radiation Oncology (2017)

    Fulltext@MSK | Save
  • Day 0 dosimetric evaluation for LDR prostate brachytherapy may be superior to day 30 assessments by providing similar quality assurance information at earlier time points
    Meeting Abstract

    King, M. T.; Cohen, G. N.; Kollmeier, M. A.; Pei, X.; Damato, A. L.; Zelefsky, M. J.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • PIK3 mutations are associated with decreased local control in brain metastases treated with radiation
    Meeting Abstract

    Lockney, N.; Wang, D.; Lin, A.; Pei, X.; Chan, T.; Yamada, Y.; Beal, K.; Yang, T. J.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time
    Journal Article

    Kollmeier, M. A.; McBride, S.; Taggar, A.; Anderson, E.; Lin, M.; Pei, X.; Weiji, S.; Voros, L.; Cohen, G.; Yamada, Y.; more...
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Dose-escalated intensity modulated radiation therapy for prostate cancer: 15-year outcomes data
    Meeting Abstract

    Weg, E. S.; Kollmeier, M. A.; McBride, S.; Pei, X.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Tumor spread through airspaces and histologic subtype predict outcomes following post-operative radiation therapy for locally advanced lung adenocarcinoma
    Meeting Abstract

    Leeman, J. E.; Shepherd, A. F.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Travis, W.; Adusumilli, P.; Jones, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • 5-year outcomes of a phase 1 dose escalation study using stereotactic body radiosurgery for patients with clinically localized prostate cancer
    Meeting Abstract

    Zelefsky, M. J.; Kollmeier, M. A.; McBride, S.; Pei, X.; Happersett, L.; Lin, M.; Cox, B. W.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Prognostic impact of tumor location and lymph node burden for patients with stage IIIA non-small cell lung cancer receiving postoperative radiation therapy
    Meeting Abstract

    Imber, B. S.; Leeman, J. E.; Shepherd, A. F.; Wild, A.; Pei, X.; Gelb, E.; Chaft, J.; Mychalczak, B. R.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A comparison of trimodality therapy versus definitive concurrent chemoradiation in patients with stage IIIA non-small cell lung cancer
    Meeting Abstract

    Shepherd, A. F.; Leeman, J. E.; Wild, A.; Imber, B. S.; Pei, X.; Gelb, E.; Yorke, E. D.; Isbell, J.; Chaft, J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • FDG-PET maximum standardized uptake value is prognostic for survival and disease-free survival in stage IIIA-N2 non-small cell lung cancer patients who receive postoperative radiation therapy
    Meeting Abstract

    Wild, A.; Shepherd, A. F.; Leeman, J. E.; Imber, B. S.; Pei, X.; Gelblum, D.; Gelb, E.; Chaft, J.; Jones, D.; Isbell, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save